Imidacloprid Licensed for Use by Mowi in Loch Ailort?

 

 

 

Scottish Salmon Watch stumbled across this interesting 'Marine Licence' issued on 18 June 2020 by the Scottish Government for Mowi's salmon farm at Ardnish in Loch Ailort (the same site at which Mowi is seeking to field trial the toxic neonicotinoid insecticide Imidacloprid).

 

 

MS 18 June 2020 Licence to deposit any sustance Ardnish

 

 

Here's an excerpt of the 'Licence to Deposit Any Substance or Object Within the Scottish Marine Area – Marine Farm':

 

MS 18 June 2020 Licence to deposit any sustance Ardnish #1

MS 18 June 2020 Licence to deposit any sustance Ardnish #1a

 

MS 18 June 2020 Licence to deposit any sustance Ardnish #2

 

MS 18 June 2020 Licence to deposit any sustance Ardnish #5 92 cages

 

MS 18 June 2020 Licence to deposit any sustance Ardnish #3

 

 

Here's a copy of the map in Annex One:

 

MS 18 June 2020 Licence to deposit any sustance Ardnish #4

 

 

 

 

 

Scottish Salmon Watch emailed SEPA (26 June 2020) asking whether this licence permitted the discharge of Imidicaloprid:

 

From: Don Staniford <salmonfarmingkills@gmail.com>
Date: Fri, Jun 26, 2020 at 3:08 PM
Subject: Mowi licence to use Imidacloprid granted on 18 June 2020 in Loch Ailort?
To: Pollard, Peter <peter.pollard@sepa.org.uk>

See: http://marine.gov.scot/ml/marine-licence-marine-farm-ardnish-loch-ailort-07263

 
 
 
Does this mean Mowi is permitted to discharge Imidacloprid wastes into Loch Ailort?
 
MS 18 June 2020 Licence to deposit any sustance Ardnish #1
 
 
 
 

In relation to a previous inquiry on Imidacloprid, SEPA told Scottish Salmon Watch (26 June 2020):

 

 

From: Pollard, Peter <Peter.Pollard@sepa.org.uk>
Date: Friday, June 26, 2020
Subject: Re: FOI re. Scientific Concerns re. Imidacloprid Use in Scottish Salmon Farming
To: "salmonfarmingkills@gmail.com" <salmonfarmingkills@gmail.com>

Dear Don,

In your email of 8th June requesting access to information held by SEPA, you asked three wider questions. Our answers to these are provided below. You will receive the information we hold relating to the elements of your request that fall under FOI/EIR in separate correspondence.

  1. Will SEPA be publishing a scientific dossier on environmental impacts of Imidacloprid (as SEPA has done so via Emamectin benzoate)?

SEPA is not planning to commission and publish a scientific dossier on the environmental impacts of imidacloprid.

The 2016 review of emamectin benzoate was prompted by indications from a study by the Scottish Association for Marine Science that the use of the medicine may be affecting crustaceans The purposes of the review were to:

(a)           determine if the environmental standards that had been established in 1999 remained scientifically valid; and

(b)          potentially derive new standards according to the latest regulatory guidance.

In the case of imidacloprid, there are currently no established coastal water environmental standards to review. There are also no authorised discharges into coastal waters.

Before we would consider authorising any discharges of imidacloprid, we would require the applicant to provide the necessary data to identify a suitable environmental standard in the form of a predicted no effect concentration. It is the responsibility of the applicant to provide the scientific information for this purpose.

Any application made that would result in a breach of an environmental standard would be refused.

  1. Will SEPA be conducting scientific studies and monitoring of impacts of Imidacloprid (as it has done so via Emamectin benzoate)?

As also noted above, SEPA has not issued any authorisations to any finfish farm-related operation to discharge imidacloprid nor is SEPA in receipt of any application to discharge imidacloprid.

If an application is made to discharge imidacloprid and an authorisation to do so granted, SEPA will carry out appropriately rigorous checks to ensure that the conditions of the authorisation are being met.

The form of the checks will depend on the particular conditions of authorisation, which will in turn depend on the details of the proposed discharge. The checks may include, for example, sampling of the discharge and environmental monitoring.

 

  1. Will Bayer/Monsanto be making available to the public their 'Confidential' work on Imidacloprid (or will the chemical company behind Imidacloprid be taking the Merck behind the scenes route)?

 

We do not have any information on the intentions of Bayer/Monsanto.

 

Yours sincerely,

Peter

Head of Ecology

Evidence & Flooding

Scottish Environment Protection Agency

 

 

A FOI reply from SEPA also dated 26 June 2020 stated:

 

SEPA FOI letter 26 June 2020 #1

 

SEPA FOI letter 26 June 2020 #2

 

 

SEPA FOI letter 26 June 2020 #3

 

SEPA FOI letter 26 June 2020 #4

 

SEPA FOI letter 26 June 2020 #5

 

SEPA FOI letter 26 June 2020 #6

Read FOI reply from SEPA in full online here

 

SEPA FOI letter 26 June 2020 Disclosure online FO191964

 

 

 

 

Another FOI reply from SEPA dated 26 June 2020 (FO191905) included:

 

SEPA FOI letter 26 June 2020 second FOI reply #1

 

SEPA FOI letter 26 June 2020 second FOI reply #2 Disclosure log

 

 

 

 

Scottish Salmon Watch's letter to SEPA's Chief Executive Terry A'Hearn dated 17 March 2020 (which has still not received a reply over three months later) is available online here

 

 

 

 

Read more via:

 

 

PR Scientific Opposition to Imidacloprid Use in Salmon Farming 8 June 2020 Tweet #2 Dave Goulson

Imidacloprid graphic Water bottle spoof

Imidacloprid graphic Will the Minister drink it

PR Scientific Opposition to Imidacloprid Use in Salmon Farming 8 June 2020 Tweet #6 bottle spoofs

 

Read more on Scottish Salmon Watch's smoking hot campaign against salmon farming online here

Gallery #5 online via Scottish Scamon

#10 Farmed Salmon Contains Cancer Causing Chemicals

Cigarette 29 Chemicals

Scroll to Top